Phase 1 Epistaxis Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Topical TOR-582 Treatment of Epistaxis in HHT

EpistaxisHereditary Hemorrhagic Telangiectasia (HHT)

Columbia University27 enrolled1 locationNCT07667413

Recruiting

Phase 1Phase 2

Treatment of Nosebleeds in the Emergency Department With Powder Tranexamic Acid

Epistaxis Nosebleed

Dr. Anne Conlin24 enrolled1 locationNCT06997796